Bristol Myers Squibb Abecma approved in European Union for triple-class exposed relapsed and refractory multiple myeloma Ruchika Sharma22 March 2024 4:02 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Commission (EC) has granted approval to Abecma (idecabtagene vicleucel;...
Takeda bags accelerated USFDA nod for Iclusig with chemotherapy in adult patients with newly diagnosed Ph+ ALL Ruchika Sharma22 March 2024 11:57 AM ISTOsaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for...
Mammography-based AI model can predict 5-year breast cancer risk: Study Medha Baranwal21 March 2024 11:30 PM ISTUSA: Duke University researchers have developed an artificial intelligence (AI) model that can predict five-year breast cancer risk from mammograms,...
Annual mammography with clinical exam is "likely sufficient" than semiannual after breast-conserving surgery: Study Medha Baranwal20 March 2024 8:00 PM ISTUSA: A recent study found that evidence is insufficient to support semi-annual mammography in the early postoperative period after breast-conserving...
Dr Reddys Labs unveils Versavo in UK for several types of cancers Ruchika Sharma20 March 2024 2:30 PM ISTHyderabad: Dr Reddy's Laboratories Ltd., a global pharmaceutical company, has announced the launch of Versavo (bevacizumab) in the United Kingdom...
AstraZeneca to acquire Fusion Pharma to accelerate development of next-generation radioconjugates to treat cancer Susmita Roy19 March 2024 4:11 PM ISTCambridge: AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company...
Can tobacco and alcohol raise the risk of head and neck cancers? Study finds out Anshika Mishra18 March 2024 7:30 PM ISTAccording to research published in the journal Molecular Medicine, consumption of tobacco and alcohol has been linked to rising cases of head and...
DNA origami vaccines for precise cancer immunotherapy: Study Anshika Mishra18 March 2024 5:00 AM ISTA team of scientists from the Wyss Institute at Harvard University, Dana-Farber Cancer Institute (DFCI), Harvard Medical School (HMS), and Korea...
Oral Iptacopan monotherapy improves outcomes in patients with paroxysmal nocturnal hemoglobinuria: NEJM Medha Baranwal15 March 2024 9:15 PM ISTFrance: A recent study has shown improved clinical and hematologic outcomes with iptacopan treatment in anti-C5-treated patients with persistent...
Bristol Myers Squibb gets USFDA accelerated nod for Breyanzi as CAR T Cell Therapy for adults with relapsed or refractory chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Susmita Roy15 March 2024 12:32 PM ISTPrinceton: Bristol Myers Squibb has announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval of...
Photobiomodulation offers safe and effective treatment for variety of skin conditions, says new research Medha Baranwal14 March 2024 11:45 PM ISTUSA: A recent medical education article published in the Journal of the American Academy of Dermatology reviews the various clinical applications of...
Novel oral hormone therapy promising for prostate cancer treatment with radiation therapy: JAMA Dr. Kamal Kant Kohli14 March 2024 11:15 PM ISTA high impact study led by Daniel Spratt, M.D., Vincent K. Smith Chair in Radiation Oncology at University Hospitals Seidman Cancer Center...
